Casali, P. G., Le Cesne, A., Velasco, A. P., Kotasek, D., Rutkowski, P., Hohenberger, P., . . . Blay, J. -. (2021). Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS). Annals of oncology, 32(4), . https://doi.org/10.1016/j.annonc.2021.01.004
Chicago-Zitierstil (17. Ausg.)Casali, Paolo G., et al. "Final Analysis of the Randomized Trial on Imatinib as an Adjuvant in Localized Gastrointestinal Stromal Tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)." Annals of Oncology 32, no. 4 (2021). https://doi.org/10.1016/j.annonc.2021.01.004.
MLA-Zitierstil (9. Ausg.)Casali, Paolo G., et al. "Final Analysis of the Randomized Trial on Imatinib as an Adjuvant in Localized Gastrointestinal Stromal Tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)." Annals of Oncology, vol. 32, no. 4, 2021, https://doi.org/10.1016/j.annonc.2021.01.004.